USPTO Registration Examination (Patent Bar)

Study content for USPTO Registration Examination (Patent Bar): notes, practice MCQs and flashcards across 27 syllabus topics. This is AI-generated draft content — citations have not yet been independently verified.

Syllabus

• MPEP Chapter 100 – Secrecy, Access, National SecurityTopic

  Secrecy orders · National security provisions

• MPEP Chapter 200 – Types, Cross-Noting, Status of ApplicationTopic

  Continuation / CIP / Divisional (35 USC 120/121) · Priority and benefit claims (35 USC 119/365) · PCT applications and national stage entry

• MPEP Chapter 300 – Ownership and AssignmentTopic

  Assignment recordal · Inventorship correction (MPEP 324) · Joint inventors

• MPEP Chapter 400 – Representative of Applicant / OwnerTopic

  Power of attorney · Practitioner conduct · Correspondence rules

• MPEP Chapter 500 – Receipt and Handling of Mail and PapersTopic

  Filing date requirements · Certificate of mailing/transmission · Express Mail / EFS-Web rules

• MPEP Chapter 600 – Parts, Form, and Content of ApplicationTopic

  Specification requirements (35 USC 112 written description, enablement, definiteness) · Claims drafting and format · Drawings requirements

• MPEP Chapter 700 – Examination of ApplicationsTopic

  Office actions and responses (37 CFR 1.111/1.113) · Restriction/election requirements · Final rejections and after-final practice

• MPEP Chapter 800 – Restriction in Applications Filed Under 35 USC 111Topic

  Restriction and election · Traverse of restriction · Rejoinder

• MPEP Chapter 900 – Prior Art, Publication, and IDSTopic

  Information Disclosure Statements (37 CFR 1.97/1.98) · Prior art categories and effective dates · Search reports

• MPEP Chapter 1000 – Matters Decided by Various USPTO OfficialsTopic

  Petitions · Supervisory decisions

• MPEP Chapter 1100 – Statutory Invention Registration / Pre-Grant PublicationTopic

  Pre-grant publication (18-month) · Non-publication request

• MPEP Chapter 1200 – AppealTopic

  Appeal to PTAB (37 CFR 41) · Brief requirements · Oral hearings

• MPEP Chapter 1300 – Allowance and IssueTopic

  Notice of allowance · Issue fee · Withdrawal from issue

• MPEP Chapter 1400 – Correction of PatentsTopic

  Reissue applications · Reissue recapture doctrine · Certificates of correction

• MPEP Chapter 1500 – Design PatentsTopic

  Design claim format · Distinctiveness · Design patent term

• MPEP Chapter 1600 – Plant PatentsTopic

  Asexual reproduction requirement · Plant patent claims

• MPEP Chapter 1700 – MiscellaneousTopic

  Deposit of biological material · Sequence rules

• MPEP Chapter 1800 – PCT ApplicationsTopic

  PCT filing and national stage (35 USC 371/365) · International search and preliminary examination · Chapter I and Chapter II procedures

• MPEP Chapter 1900 – ProtestTopic

  Third-party submissions pre-grant

• MPEP Chapter 2000 – Duty of DisclosureTopic

  37 CFR 1.56 duty · Inequitable conduct concepts

• MPEP Chapter 2100 – PatentabilityTopic

  35 USC 101 – Subject matter eligibility (Alice/Mayo framework) · 35 USC 102 – Novelty and AIA prior art rules · 35 USC 103 – Obviousness (KSR, Graham v. John Deere factors)

• MPEP Chapter 2200 – Citation of Prior Art / Ex Parte ReexaminationTopic

  Ex parte reexamination procedure · Substantial new question of patentability

• MPEP Chapter 2300 – Interference / Derivation ProceedingsTopic

  AIA derivation proceedings · Pre-AIA interference concepts

• MPEP Chapter 2400 – Biotechnology / Sequence ListingsTopic

  Nucleotide/amino acid sequence rules · Deposit requirements

• MPEP Chapter 2500 – Maintenance FeesTopic

  Maintenance fee schedule · Surcharge · Petition to accept late payment

• MPEP Chapter 2600–2900 – Inter Partes Reexamination, Inter Partes Review, Post-Grant ReviewTopic

  Inter partes reexamination (legacy) · Inter partes review (IPR) under AIA · Post-grant review (PGR)

• 37 CFR Rules of Practice (cross-cutting)Topic

  Filing fees and fee schedules · Small/micro entity status · Time periods and extensions of time

• Association for Molecular Pathology v. Myriad Genetics, Inc.

  Is a naturally occurring DNA segment patent-eligible under 35 USC 101?

  569 U.S. 576
• Association for Molecular Pathology v. Myriad Genetics, Inc.

  Why is cDNA patent-eligible when natural DNA is not?

  569 U.S. 576
• Diamond v. Chakrabarty

  What test did the Supreme Court apply in Diamond v. Chakrabarty for § 101 patent eligibility?

  447 U.S. 303